The success of Axcelon’s two-pronged strategy is predicated
on its Management Team and Board of Directors. Key
Team members include: President and CEO,
Dr.Chandra J. Panchal, PhD. has an extensive experience
in both public and private biotechnology companies as well
as in developing and marketing advanced wound care
products. His formidable experience as a Biotechnology
entrepreneur and his global network in the area of wound care
will ensure smooth launches for
NanoDerm™ and NanoDerm Plus™. Axcelon’s Chief Scientific Advisor is Dr. Wan-Kei Wan, a recognized leader in the Microbial Cellulose
field. Dr. Xinsheng Li, of 20 years experience in synthetic chemistry and biomaterials, acts as a Principal Scientist. Through a strategic alliance with the